Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial - The Lancet Oncology
Lenalidomide with Low- or High-Dose Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma (MM) | Research To Practice
Maintenance Therapy Dosing | REVLIMID® (lenalidomide) for MM
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study - The Lancet Oncology
Management of cardiovascular risk in patients with multiple myeloma | Blood Cancer Journal
REVLIMID® (lenalidomide) Dosing for Multiple Myeloma
Frontiers | Dose Super-Resolution in Prostate Volumetric Modulated Arc Therapy Using Cascaded Deep Learning Networks
ICARIA Study Updates | Int'l Myeloma Foundation
Benchmarking Monte-Carlo dose calculation for MLC CyberKnife treatments | Radiation Oncology | Full Text
IMRT dose verification considering passing rate and respiratory motion
Principles of CT: Radiation Dose and Image Quality | Journal of Nuclear Medicine Technology
Dose-volume histogram of head and neck patient 8 showing the planning... | Download Scientific Diagram
Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma | Haematologica
Cureus | Dose Optimization for Single-Channel Vaginal Cylinder High-Dose-Rate Brachytherapy: A Double Prescription Method for Patients With Endometrial Adenocarcinoma
Monte Carlo calculations of radiotherapy dose distributions within and around orthopaedic implants - Physics and Imaging in Radiation Oncology
Solved The optimum dose of fluoride in drinking water is | Chegg.com
Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy | Haematologica
REVLIMID® (lenalidomide) Dosing for del 5q Myelodysplastic Syndrome
GP dose fall-off (%/mm) representation as a function of the volume and... | Download Scientific Diagram
Relapsed/Refractory MM - Expert Guidance: Myeloma - Module - Myeloma Therapeutic Strategies - Oncology - Clinical Care Options
Daratumumab Split First Versus Single Dosing Schedule Among Patients With Multiple Myeloma Treated in a US Community Oncology Setting: A Retrospective Observational Study - ScienceDirect
Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma | Leukemia
Lecture 5: More Medical Abbreviations and Dosage Calculations Using Body Weight and Surface Area
Radiation Dose Reporting | Department of Radiology | UC Davis Health
